279 related articles for article (PubMed ID: 24169548)
21. Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.
Zhang X; Wang F; Chen X; Chen Y; Ma L
J Neurochem; 2008 Jul; 106(2):781-92. PubMed ID: 18419762
[TBL] [Abstract][Full Text] [Related]
22. Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2.
Hasbi A; Devost D; Laporte SA; Zingg HH
Mol Endocrinol; 2004 May; 18(5):1277-86. PubMed ID: 14976224
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
24. GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.
Iacovelli L; Franchetti R; Masini M; De Blasi A
Mol Endocrinol; 1996 Sep; 10(9):1138-46. PubMed ID: 8885248
[TBL] [Abstract][Full Text] [Related]
25. The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion.
Murray RD; Kim K; Ren SG; Lewis I; Weckbecker G; Bruns C; Melmed S
J Clin Endocrinol Metab; 2004 Jun; 89(6):3027-32. PubMed ID: 15181094
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
27. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
Tseng CC; Zhang XY
Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
[TBL] [Abstract][Full Text] [Related]
28. Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas.
Orciani M; Caffarini M; Sorgentoni G; Ricciuti RA; Arnaldi G; Di Primio R
Pituitary; 2017 Apr; 20(2):251-260. PubMed ID: 27796709
[TBL] [Abstract][Full Text] [Related]
29. Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts.
Spurney RF
Calcif Tissue Int; 2003 Aug; 73(2):153-60. PubMed ID: 14565597
[TBL] [Abstract][Full Text] [Related]
30. Expression and regulation of G protein-coupled receptor kinase 5 and beta-arrestin-1 in rat thyroid FRTL5 cells.
Nagayama Y; Tanaka K; Namba H; Yamashita S; Niwa M
Thyroid; 1996 Dec; 6(6):627-31. PubMed ID: 9001199
[TBL] [Abstract][Full Text] [Related]
31. PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion.
Shimon I; Rubinek T; Hadani M; Alhadef N
J Endocrinol Invest; 2004 Sep; 27(8):721-7. PubMed ID: 15636423
[TBL] [Abstract][Full Text] [Related]
32. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
33. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
34. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
35. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
[TBL] [Abstract][Full Text] [Related]
36. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.
Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
Proc Natl Acad Sci U S A; 2012 May; 109(18):7055-60. PubMed ID: 22509025
[TBL] [Abstract][Full Text] [Related]
37. 17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1.
Dominguez R; Hu E; Zhou M; Baudry M
J Neurosci; 2009 Apr; 29(13):4228-38. PubMed ID: 19339617
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway.
Ogasawara J; Sanpei M; Rahman N; Sakurai T; Kizaki T; Hitomi Y; Ohno H; Izawa T
FASEB J; 2006 Feb; 20(2):350-2. PubMed ID: 16368719
[TBL] [Abstract][Full Text] [Related]
39. Synergistic regulation of m2 muscarinic acetylcholine receptor desensitization and sequestration by G protein-coupled receptor kinase-2 and beta-arrestin-1.
Schlador ML; Nathanson NM
J Biol Chem; 1997 Jul; 272(30):18882-90. PubMed ID: 9228066
[TBL] [Abstract][Full Text] [Related]
40. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
Hurlé MA
J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
